Clinical characteristics and outcomes of patients with haematologic malignancies and COVID-19 suggest that prolonged SARS-CoV-2 carriage is an important issue
Robin Arcani(Inserm), Gilles Kaplanski(Hôpital Sainte-Marguerite), Julie Lachamp(Assistance Publique Hôpitaux de Marseille), Marie Koubi(Hôpital de la Conception), Laure Farnault(Aix-Marseille Université), Régis Costello(Inserm), Geoffroy Venton(Inserm), Julien Colle(Inserm), Raphaël Cauchois(Inserm), R Jean(Hôpital de la Conception), Pierre‐André Jarrot(Inserm), Antoine Tichadou(Assistance Publique Hôpitaux de Marseille), Arthur Boyer(Assistance Publique Hôpitaux de Marseille), Anne‐Laure Couderc(Centre National de la Recherche Scientifique)
Cited by 22
Related Papers
Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio‐Oncology Guidelines
|Journal of the American Heart Association|2020|298
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
|Blood|2021|157
Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors
|Blood Cancer Journal|2016|74
High incidence of atrial fibrillation in patients treated with ibrutinib
|Open Heart|2019|72
Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN
|Journal of the American Society of Nephrology|2015|61